PharmacyCodes



Urokinase-type plasminogen activator precursor en es it fr

Urokinase-type plasminogen activator precursor Brand names, Urokinase-type plasminogen activator precursor Analogs

Urokinase-type plasminogen activator precursor Brand Names Mixture

  • No information avaliable

Urokinase-type plasminogen activator precursor Chemical_Formula

C1376H2145N383O406S18

Urokinase-type plasminogen activator precursor RX_link

http://www.rxlist.com/cgi/pharmclips2.cgi?keyword=%20Abbokinase%AE

Urokinase-type plasminogen activator precursor fda sheet

http://redpoll.pharmacy.ualberta.ca/DrugBank/Urok001-FDA.pdf

Urokinase-type plasminogen activator precursor msds (material safety sheet)

Urokinase-type plasminogen activator precursor Synthesis Reference

PMID 2987867

Urokinase-type plasminogen activator precursor Molecular Weight

31126.5

Urokinase-type plasminogen activator precursor Melting Point

76 oC at pH 4.5 (Nowak, U.K. et al., Biochemistry 33:2951-2960 (1994).

Urokinase-type plasminogen activator precursor H2O Solubility

No information avaliable

Urokinase-type plasminogen activator precursor State

Liquid

Urokinase-type plasminogen activator precursor LogP

-0.466

Urokinase-type plasminogen activator precursor Dosage Forms

Powder for solution; Solution (IV infusion)

Urokinase-type plasminogen activator precursor Indication

For the treatment of pulminary embolism, coronary artery thrombosis and IV catheter clearance

Urokinase-type plasminogen activator precursor Pharmacology

Urokinase is used for the treatment of pulmonary embolisms. The low molecular weight form of human urokinase consists of an A chain of 2,000 daltons linked by a sulfhydryl bond to a B chain of 30,400 daltons. Urokinase is an enzyme (protein) produced by the kidney, and found in the urine. There are two forms of urokinase which differ in molecular weight but have similar clinical effects. Urokinase is the low molecular weight form. Urokinase acts on the endogenous fibrinolytic system. It converts plasminogen to the enzyme plasmin. Plasmin degrades fibrin clots as well as fibrinogen and some other plasma proteins.

Urokinase-type plasminogen activator precursor Absorption

No information avaliable

Urokinase-type plasminogen activator precursor side effects and Toxicity

No information avaliable

Urokinase-type plasminogen activator precursor Patient Information

http://www.drugs.com/PDR/Abbokinase.html

Urokinase-type plasminogen activator precursor Organisms Affected

Humans and other mammals